Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: cleanroom SOP for biologics manufacturing

Biosimilars: SOP for Western Blotting for Protein Expression – V 2.0

Posted on By

Biosimilars: SOP for Western Blotting for Protein Expression – V 2.0 Standard Operating Procedure for Western Blotting for Protein Expression in Biosimilar Cell Clones Department Biosimilars SOP No. SOP/BS/014/2025 Supersedes SOP/BS/014/2022 Page No. Page 1 of 12 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the standardized procedure for detecting…

Read More “Biosimilars: SOP for Western Blotting for Protein Expression – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for ELISA-Based Screening of Clones – V 2.0

Posted on By

Biosimilars: SOP for ELISA-Based Screening of Clones – V 2.0 Standard Operating Procedure for ELISA-Based Screening of Clones in Biosimilar R&D Department Biosimilars SOP No. SOP/BS/013/2025 Supersedes SOP/BS/013/2022 Page No. Page 1 of 12 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To establish a standardized method for using Enzyme-Linked Immunosorbent Assay…

Read More “Biosimilars: SOP for ELISA-Based Screening of Clones – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Colony Screening and Expression Analysis – V 2.0

Posted on By

Biosimilars: SOP for Colony Screening and Expression Analysis – V 2.0 Standard Operating Procedure for Colony Screening and Expression Analysis in Biosimilar Cell Line Development Department Biosimilars SOP No. SOP/BS/012/2025 Supersedes SOP/BS/012/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the standardized method for…

Read More “Biosimilars: SOP for Colony Screening and Expression Analysis – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Limiting Dilution Cloning – V 2.0

Posted on By

Biosimilars: SOP for Limiting Dilution Cloning – V 2.0 Standard Operating Procedure for Limiting Dilution Cloning in Biosimilar Development Department Biosimilars SOP No. SOP/BS/011/2025 Supersedes SOP/BS/011/2022 Page No. Page 1 of 12 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define a standard procedure for isolating single-cell-derived clones by limiting dilution…

Read More “Biosimilars: SOP for Limiting Dilution Cloning – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Selection of Stably Transfected Clones – V 2.0

Posted on By

Biosimilars: SOP for Selection of Stably Transfected Clones – V 2.0 Standard Operating Procedure for Selection of Stably Transfected Clones in Biosimilar R&D Department Biosimilars SOP No. SOP/BS/010/2025 Supersedes SOP/BS/010/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the process for selecting, isolating, and…

Read More “Biosimilars: SOP for Selection of Stably Transfected Clones – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Transient Transfection Methods – V 2.0

Posted on By

Biosimilars: SOP for Transient Transfection Methods – V 2.0 Standard Operating Procedure for Transient Transfection Methods in Biosimilar R&D Department Biosimilars SOP No. SOP/BS/009/2025 Supersedes SOP/BS/009/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the procedure for transient transfection of mammalian cells using lipid-mediated…

Read More “Biosimilars: SOP for Transient Transfection Methods – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Agarose Gel Electrophoresis – V 2.0

Posted on By

Biosimilars: SOP for Agarose Gel Electrophoresis – V 2.0 Standard Operating Procedure for Agarose Gel Electrophoresis in Biosimilar R&D Department Biosimilars SOP No. SOP/BS/008/2025 Supersedes SOP/BS/008/2022 Page No. Page 1 of 10 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To establish a standardized procedure for performing agarose gel electrophoresis to separate,…

Read More “Biosimilars: SOP for Agarose Gel Electrophoresis – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Restriction Enzyme Digestion and Mapping – V 2.0

Posted on By

Biosimilars: SOP for Restriction Enzyme Digestion and Mapping – V 2.0 Standard Operating Procedure for Restriction Enzyme Digestion and Mapping in Biosimilar Research Department Biosimilars SOP No. SOP/BS/007/2025 Supersedes SOP/BS/007/2022 Page No. Page 1 of 11 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To establish a standard method for performing restriction…

Read More “Biosimilars: SOP for Restriction Enzyme Digestion and Mapping – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Plasmid Amplification and Purification – V 2.0

Posted on By

Biosimilars: SOP for Plasmid Amplification and Purification – V 2.0 Standard Operating Procedure for Plasmid Amplification and Purification in Biosimilar Development Department Biosimilars SOP No. SOP/BS/006/2025 Supersedes SOP/BS/006/2022 Page No. Page 1 of 12 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To define the process for amplifying and purifying plasmid DNA…

Read More “Biosimilars: SOP for Plasmid Amplification and Purification – V 2.0” »

Biosimilars V 2.0

Biosimilars: SOP for Transformation and Electroporation – V 2.0

Posted on By

Biosimilars: SOP for Transformation and Electroporation – V 2.0 Standard Operating Procedure for Transformation and Electroporation in Biosimilar Development Department Biosimilars SOP No. SOP/BS/005/2025 Supersedes SOP/BS/005/2022 Page No. Page 1 of 13 Issue Date 04/05/2025 Effective Date 06/05/2025 Review Date 04/05/2026 1. Purpose To outline the standardized procedure for introducing recombinant plasmids into host cells…

Read More “Biosimilars: SOP for Transformation and Electroporation – V 2.0” »

Biosimilars V 2.0

Posts pagination

Previous 1 2 3 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme